patient flow management News
-
Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.
Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced the closing of a definitive asset purchase agreement under which Flagship Biosciences, Inc. has acquired the Company’s Pharma Services business (Interpace Pharma Solutions). The Company will use the proceeds from the transaction for ...
-
Beazley and PeriGen to Collaborate on Patient Safety Programs Addressing Obstetric Safety
PeriGen, the global leader in developing artificial intelligence (AI) systems for obstetrics, has partnered with specialist insurer Beazley to offer its safety-based obstetric program to Beazley’s healthcare clients in the United States. Under the arrangement, Beazley will facilitate distribution of PeriGen’s AI-powered early warning system for labor and delivery, PeriWatch ...
-
Sight Sciences Receives FDA 510(k) Clearance of the TearCare System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the TearCare® System for the treatment of meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED). The indication ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you